Skip to content

GI Cancer Icon Changing outcomes for people with GIgastro-intestinal cancer

Donate Now
  • Make a Single Gift
  • Give a Monthly Gift
  • Give In Memory
  • A Gift In Your Will
  • Fundraise For Us
MENUMENU
  • Home
  • About
    • About Us
      • Chair’s Message
      • Board of Directors
      • Staff Members
      • Achievements
      • Scientific Advisory Committee
      • Upper GI and Lower GI Working Parties
      • Consumer Advisory Panel
      • Corporate Support
      • Annual Report
  • GI Cancer
    • What is GI cancer?
      • Oesophageal Cancer
      • Liver Cancer
      • Stomach Cancer
      • Gallbladder & Biliary Tract Cancer
      • Pancreatic Cancer
      • Gastro-Intestinal Stromal Tumour (GIST)
      • Neuroendocrine Tumours (NETs)
      • Colorectal Cancer
      • Small Bowel Cancer
      • Anal Cancer
    • Resources
      • Videos
      • Webinars
      • Cancer FAQ
      • Support Groups
      • Recommended Reading
      • Information Booklets
      • Recipes
      • Helpful Links
      • Newsletter Sign-up
    • News
      • Stories
      • Community Forums
  • Trials & Research
    • Clinical Trials
      • Concepts - In Development
      • Trials - In Development
      • Trials - Open
      • Trials - In Follow-up
      • Trials - Completed
      • Trials - Endorsed Studies
      • Participating Trial Centres
      • Clinical Trial FAQs
      • Genesis of a Clinical Trial
    • Research
      • Translational Research
      • Publications and Presentations
  • Health Professionals
    • AGITG
      • Membership
      • Achievements
      • Funding
    • Clinical Trials
      • AGITG Trial News
      • Concepts - In Development
      • Trials - In Development
      • Trials - Open
      • Trials - In Follow-up
      • Trials - Completed
      • Trials - Endorsed Studies
      • Participating Trial Centres
    • Research
      • Research Priorities
      • Upper GI and Lower GI Working Parties
      • Idea Generation Workshop
      • Endorsed Study Model
      • Translational Research Model
      • Publications and Presentations
      • Tele-Trial Model
    • Awards and Grants
      • AGITG Innovation Fund
      • New Concepts Symposium
      • John Zalcberg OAM Award
      • Merck-AGITG Clinical Research Fellowship in GI Cancer
      • Best of Posters & Fast Forward
      • Outstanding Site Award
      • AGITG Member Fundraiser of the Year Award
    • CommNETs
      • Presentations & Publications
      • Projects & Working Groups
      • Newsletters
      • Annual Research Workshop
      • CommNETs Committees
      • CommNETs Committee
      • Preceptorships
      • Policies
      • Contacts
    • News
      • Events & Education
        • Annual Scientific Meeting
  • ASM
  • Get Involved
    • The Gutsy Challenge
      • 2021 Gutsy Challenge Adventures
      • Past Gutsy Challenge Adventures
    • Fundraise
      • Start a Gutsy Fundraiser
      • Walk, Run or Ride for Research
      • Create Your Own Fundraiser
      • Raise Your Fork for Research
      • Workplace Fundraising Ideas
    • Donate
      • Where Does My Gift Go?
      • Make a Single Gift
      • Give a Monthly Gift
      • Direct Deposit Donation
      • A Gift In Your Will
      • Give In Memory
      • Workplace Giving
    • Volunteer
      • Corporate Support
  • Contact
  • Newsletter Sign-up
  • Member Login
Corporate Support - GI Cancer

Corporate Support

Corporate Support

Corporate support helps the GI Cancer Institute unlock the answers to better treatments for the 28,600 Australians diagnosed with gastro-intestinal (GI) cancer each year.

With 39 Australians losing their battle to the disease every day, the stakes are high.

The GI Cancer Institute aims to raise money for GI cancer clinical trials research conducted by the Australasian Gastro-Intestinal Trials Group (AGITG). The AGITG is comprised of over 1,000 medical professionals who volunteer their time. AGITG research is conducted independently of the corporate supporters of the GI Cancer Institute.

We thank the following companies for their recent support.

Share

Corporate Sponsors – Platinum


Servier

Servier possesses a unique cultural heritage as an international, independent, French research-based ethical pharmaceutical Company governed by a non-profit foundation. Servier produces innovative drugs for doctors and their patients around the world. At the same time, driven by the medical needs of humankind and advances in science and technology, Servier strives to meet the demands of the future.

Additional information can be found at www.servier.com.au.


Corporate Sponsors – Gold


Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Additional information can be found at www.amgen.com.au


AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses
on the discovery, development and commercialisation of prescription medicines,
primarily for the treatment of diseases in three therapy areas – Respiratory &
Autoimmunity, Cardiovascular & Metabolic Disease and Oncology.


The Company is also active in inflammation, infection and neuroscience through
numerous collaborations. AstraZeneca operates in over 100 countries and its
innovative medicines are used by millions of patients worldwide.


Corporate Sponsors - Silver


specialised therapeutics

Specialised Therapeutics

Specialised Therapeutics is a bio-pharmaceutical company dedicated to working with leading international pharmaceutical and diagnostic companies to provide patient access to innovative healthcare solutions.

With the highest professional and ethical standards we commercialise therapies and technologies that uniquely fulfil the unmet medical needs of our community.

The Specialised Therapeutics portfolio and pipeline at present encompasses oncology, haematology, urology and ophthalmology.

In November 2014, ABRAXANE ® (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine was listed on the Pharmaceutical Benefits Scheme for eligible patients with metastatic pancreatic cancer.
Additional information can be found at www.specialisedtherapeutics.com.au

 


Become a partner or Sponsor

If you would like to become a partner or sponsor of the GI Cancer Institute, please contact us at 1300 666 769.

© Copyright AGITG 2017 Privacy Terms and Conditions

Registered Charity
Gastro Intestinal Cancer Institute Logo
  • Home
  • About
    • About Us
      • Chair’s Message
      • Board of Directors
      • Staff Members
      • Achievements
      • Scientific Advisory Committee
      • Upper GI and Lower GI Working Parties
      • Consumer Advisory Panel
      • Corporate Support
      • Annual Report
  • GI Cancer
    • What is GI cancer?
      • Oesophageal Cancer
      • Liver Cancer
      • Stomach Cancer
      • Gallbladder & Biliary Tract Cancer
      • Pancreatic Cancer
      • Gastro-Intestinal Stromal Tumour (GIST)
      • Neuroendocrine Tumours (NETs)
      • Colorectal Cancer
      • Small Bowel Cancer
      • Anal Cancer
    • Resources
      • Videos
      • Webinars
      • Cancer FAQ
      • Support Groups
      • Recommended Reading
      • Information Booklets
      • Recipes
      • Helpful Links
      • Newsletter Sign-up
    • News
      • Stories
    • Engage
      • Community Forums
  • Trials & Research
    • Clinical Trials
      • Concepts – In Development
      • Trials – In Development
      • Trials – Open
      • Trials – In Follow-up
      • Trials – Completed
      • Trials – Endorsed Studies
      • Participating Trial Centres
      • Clinical Trial FAQs
      • Genesis of a Clinical Trial
    • Research
      • Translational Research
      • Publications and Presentations
  • Health Professionals
    • AGITG
      • Membership
      • Achievements
      • Funding
    • Clinical Trials
      • AGITG Trial News
      • Concepts – In Development
      • Trials – In Development
      • Trials – Open
      • Trials – In Follow-up
      • Trials – Completed
      • Trials – Endorsed Studies
      • Participating Trial Centres
    • Research
      • Research Priorities
      • Upper GI and Lower GI Working Parties
      • Idea Generation Workshop
      • Endorsed Study Model
      • Translational Research Model
      • Publications and Presentations
      • Tele-Trial Model
    • Awards and Grants
      • AGITG Innovation Fund
      • New Concepts Symposium
      • John Zalcberg OAM Award
      • Merck-AGITG Clinical Research Fellowship in GI Cancer
      • Best of Posters & Fast Forward
      • Outstanding Site Award
      • AGITG Member Fundraiser of the Year Award
    • CommNETs
      • Presentations & Publications
      • Projects & Working Groups
      • Newsletters
      • Annual Research Workshop
      • CommNETs Committees
      • CommNETs Committee
      • Preceptorships
      • Policies
      • Contacts
    • News
      • Events & Education
        • Annual Scientific Meeting
  • ASM
  • Get Involved
    • The Gutsy Challenge
      • 2021 Gutsy Challenge Adventures
      • Mt Himlung Himal Ascent – Nepal 2021
      • Past Gutsy Challenge Adventures
    • Fundraise
      • Start a Gutsy Fundraiser
      • Walk, Run or Ride for Research
      • Create Your Own Fundraiser
      • Raise Your Fork for Research
      • Workplace Fundraising Ideas
    • Donate
      • Where Does My Gift Go?
      • Make a Single Gift
      • Give a Monthly Gift
      • Direct Deposit Donation
      • A Gift In Your Will
      • Give In Memory
      • Workplace Giving
    • Volunteer
      • Corporate Support
  • Contact

GI Cancer Icon Changing outcomes for people with GIgastro-intestinal cancer

Donate Now